杭州旺华药业

Hangzhou Wanghua Pharmaceutical is a clinical-stage biopharmaceutical company based in Hangzhou, China, dedicated to the discovery and development of innovative small molecule drugs. The company focuses on therapeutic areas with significant unmet medical needs, particularly oncology and metabolic disorders. Their lead programs involve novel inhibitors targeting specific pathways in cancer cell growth and metabolic regulation. Wanghua Pharmaceutical leverages its internal R&D capabilities to advance a pipeline of candidates from discovery through clinical trials. The company is led by a team of experienced industry veterans and has established a presence in the Hangzhou high-tech pharmaceutical cluster.